A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)
Clinical trial NCT00769132 · COMPLETED
Trial details
- NCT number
- NCT00769132
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-03
- Primary completion
- 2007-10-13
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.